The ICB is developing a single, integrated and digitally enabled CVD prevention and optimisation pathway across Norfolk and Suffolk, with an initial focus on hypertension and lipid management. The programme is intended to replace fragmented, reactive activity with a coordinated pathway that connects identification, assessment, clinical review, treatment initiation and optimisation, behaviour-change support, monitoring and follow-up. The pathway will support delivery of the Cardiovascular Disease Modern Service Framework priorities for hypertension and cholesterol, while also supporting a broader shift towards proactive population health management, neighbourhood delivery, care closer to home and reduction of health inequalities. The proposed service will bring together existing system assets and additional capacity. It is expected to support consistent standards across the ICB footprint while allowing delivery to be tailored to local population need, including Core20PLUS5 populations and deprived, rural, coastal and other underserved communities.

The ICB intends to commission the service through a single Lead Provider arrangement. The Lead Provider will hold overall accountability for coordinating and delivering the end-to-end pathway and will be expected to work through an appropriately governed consortium and/or subcontracted network where specialist capabilities are required.